Amyris Engages FLG Partners

June 4, 2019 –  Amyris, Inc. (NASDAQ: AMYR) announced today that FLG partner Jonathan Wolter has been engaged as interim Chief Financial Officer. Company press release. Company Form 8-K.

Read More
Immersion Corp Engages FLG Partners

May 14, 2019 Immersion Corp (NASDAQ: IMMR) announced today that FLG partner, Cal Hoagland, has been engaged as interim Chief Financial Officer. Company Form 8k.

Read More
Hotel Tonight To Be Acquired by Airbnb

March 7, 2019 San Francisco, CA – Hotel Tonight announced today that it is to be acquired by AirBNB to expand the mobile home-sharing company’s hotel and travel offerings.  FLG partner, Laureen DeBuono assisted Hotel Tonight as its Interim CFO to get the deal negotiated and executed. Read more here.

Read More
Oyster Point Raises $93 Million for Phase 3 Trials of Novel Treatment for Dry Eye Disease

PRINCETON, N.J., February 26, 2019 – FLG Partner’s client, Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company has announced a $93 million Series B financing. The round was co-led by Invus Opportunities and Flying L Partners in collaboration with Falcon Vision. Existing investors New Enterprise Associates (NEA) and…Read More

Read More
Cortexyme Announces Key Leadership Appointments to Support Next Stage of Growth

FLG client, Cortexyme, a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s disease (AD) and other degenerative disorders, announced effective January 2019, two key leadership appointments. Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime…Read More

Read More